America has a new weapon in the fight against obesity. The Food and Drug Administration (FDA) has approved a new weight loss drug, Wegovy, for people who are obese or overweight. and have at least one weight-related medical problem
Dr Domenica Rubino, director of the Washington Center for Weight Control and Research, said: “We have to think about obesity as well as high blood pressure. high cholesterol and diabetes
Rubino said those taking existing diet pills lost an average of 7% to 9% of their body weight. “People who want to lose 10%, 15%, 20%, we need tools,” she said.
During the 16-month study, patients on Wegovy lost an average of 17% of their body weight. Side effects included diarrhea and nausea. This usually resolves with slowly increasing the dose. Patients who discontinued the drug lost more than half their weight.
Participant Lisa Robillard lost 63 pounds. She said she had previously tried fad diets or other methods. that she thought would help her lose weight.
“I’m not hungry between meals. which had never been heard before for me. I was full faster and the cravings disappeared,” she said of the new drug.
Wegovy is similar to the diabetes drug Ozempic, which has been prescribed for weight loss. Both drugs mimic natural hormones that help control appetite. Wegovy is approved for long-term use. And it is recommended to pair it with diet and exercise.
“These hormones really affect signals in the brain,” Rubino said. “It’s not really about commitment. It’s much more complicated. This physiology is very strong and it’s not your fault.”